Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KPNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SOD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB561 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDCA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCMT1-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC389906 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM186 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPZL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBL1X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNLIPRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724532 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM222B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on